title: Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.
abstract: Vaccines are one of the greatest achievements of mankind, and have saved millions of lives over the last century. Paradoxically, little is known about the physiological mechanisms that mediate immune responses to vaccines perhaps due to the overall success of vaccination, which has reduced interest into the molecular and physiological mechanisms of vaccine immunity. However, several important human pathogens including influenza virus still pose a challenge for vaccination, and may benefit from immune-based strategies. Although influenza reverse genetics has been successfully applied to the generation of live-attenuated influenza vaccines (LAIVs), the addition of molecular tools in vaccine preparations such as tracer components to follow up the kinetics of vaccination in vivo, has not been addressed. In addition, the recent generation of mouse models that allow specific depletion of leukocytes during kinetic studies has opened a window of opportunity to understand the basic immune mechanisms underlying vaccine-elicited protection. Here, we describe how the combination of reverse genetics and chimeric mouse models may help to provide new insights into how vaccines work at physiological and molecular levels, using as example a recombinant, cold-adapted, live-attenuated influenza vaccine (LAIV). We utilized laboratory-generated LAIVs harboring cell tracers as well as competitive bone marrow chimeras (BMCs) to determine the early kinetics of vaccine immunity and the main physiological mechanisms responsible for the initiation of vaccine-specific adaptive immunity. In addition, we show how this technique may facilitate gene function studies in single animals during immune responses to vaccines. We propose that this technique can be applied to improve current prophylactic strategies against pathogens for which urgent medical countermeasures are needed, for example influenza, HIV, Plasmodium, and hemorrhagic fever viruses such as Ebola virus.
authors.affiliation: Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.
authors.forename: José Vicente
authors.initials: JV
authors.lastname: Pérez-Girón
authors.affiliation: Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.
authors.forename: Sergio
authors.initials: S
authors.lastname: Gómez-Medina
authors.affiliation: Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.
authors.forename: Anja
authors.initials: A
authors.lastname: Lüdtke
authors.affiliation: Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology; cesar.munoz-fontela@hpi.uni-hamburg.de.
authors.forename: Cesar
authors.initials: C
authors.lastname: Munoz-Fontela
mesh_terms: D000818:Animals; D002678:Chimera; D003713:Dendritic Cells / Q000276:immunology; D005260:Female; D057809:HEK293 Cells; D006801:Humans; D018928:Immunity, Mucosal / Q000187:drug effects*; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053121:Influenza A Virus, H2N2 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D013601:T-Lymphocytes / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology
chemical_list: D007252:Influenza Vaccines; D014614:Vaccines, Synthetic